A Phase 1, Single-center, Randomized, Open-label, Crossover Study to Assess the Relative Bioavailability of Phase III Tablet Formulation Candidates in Healthy Adult Subjects
Phase of Trial: Phase I
Latest Information Update: 24 Jun 2015
At a glance
- Drugs Cabotegravir (Primary)
- Indications HIV infections
- Focus Pharmacokinetics
- Sponsors ViiV Healthcare
- 19 Jun 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 05 May 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 22 Mar 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.